Cargando…

ODP205 Hepatic steatosis induced by Nicotine plus Coca Cola is prevented by Nicotinamide riboside (NR) that increases mitochondrial NAD+

: Type 2 diabetes has emerged as an important risk factor for poor prognosis in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hyperglycemia can independently predispose the patients with SARS-CoV-2 to adverse outcomes, irrespective of the diagnosis of diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedman, Theodore C, Espinoza-Derout, Jorge, Kamrul, Hasan, Molina-Mancio, Jocelyn, Martínez, Jason, Lao, Candice, Wilson, Julian, Sinha-Hikim, Amiya, Rivera, Juan-Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628119/ http://dx.doi.org/10.1210/jendso/bvac150.657

Ejemplares similares

MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
por: Espinoza-Derout, Jorge, et al.
Publicado: (2019)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

La Coca-Cola de México
por: Solana Olivares, Fernando
Publicado: (1999)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

Coca-Cola – a model of transparency in research partnerships? A network analysis of Coca(-)Cola’s research funding (2008–2016)
por: Serôdio, Paulo M, et al.
Publicado: (2018)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
por: Sverkeli, Lars Jansen, et al.
Publicado: (2021)

The Effect of Nicotinamide Riboside, an NAD + Precursor, on Glycolysis and NAD + Salvage Pathway in Alcohol-Stimulated Macrophages
por: Kang, Hyunju, et al.
Publicado: (2022)

An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
por: Airhart, Sophia E., et al.
Publicado: (2017)

Bezoar in a Pediatric Oncology Patient Treated with Coca-Cola
por: Naramore, Sara, et al.
Publicado: (2015)

Public Meets Private: Conversations Between Coca‐Cola and the CDC
por: MAANI HESSARI, NASON, et al.
Publicado: (2019)

Gastric Xylobezoar Treated with Continuous Enteral Coca-Cola® Infusion
por: Gangadharan Nambiar, Gopinathan, et al.
Publicado: (2022)

NAD(+) augmentation with nicotinamide riboside improves lymphoid potential of Atm(−/−) and old mice HSCs
por: Zong, Le, et al.
Publicado: (2021)

Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis
por: Espinoza-Derout, Jorge, et al.
Publicado: (2019)

Surface Evaluation of Aligners after Immersion in Coca-Cola and Orange Juice
por: Warnecki, Maciej, et al.
Publicado: (2022)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017)

Induction of the nicotinamide riboside kinase NAD(+) salvage pathway in a model of sarcoplasmic reticulum dysfunction
por: Doig, Craig L., et al.
Publicado: (2020)

SUN-603 Electronic Cigarette Exposure Induces Pro-Inflammatory Changes in Adipose Tissue in Apolipoprotein E (APOE) Knockout Mice
por: Espinoza-Derout, Jorge, et al.
Publicado: (2020)

A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor
por: Giroud-Gerbetant, Judith, et al.
Publicado: (2019)

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults
por: Martens, Christopher R., et al.
Publicado: (2018)

Metabolic Disease, NAD Metabolism, Nicotinamide Riboside, and the Gut Microbiome: Connecting the Dots from the Gut to Physiology
por: Sauve, Anthony A.
Publicado: (2022)

Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease
por: Ryu, Woo‐In, et al.
Publicado: (2022)

RF32 | PSUN44 CARF Regulates Non-Alcoholic Fatty Liver Diseases (NAFLD) by Controlling ER Stress and Lipogenesis in Hepatic Cells.
por: Friedman, Theodore, et al.
Publicado: (2022)

Persimmon bezoar successfully treated by oral intake of Coca-Cola: a case report
por: Hayashi, Kazuki, et al.
Publicado: (2008)

‘We only got Coca-Cola’: Disability and the paradox of (dis)empowerment in Southeast Nigeria
por: Nwokorie, Okechukwu V., et al.
Publicado: (2019)

Trichobezoar effectively treated with direct endoscopic injection of Coca‐Cola: A case report
por: Matsuoka, Ryo, et al.
Publicado: (2023)

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
por: Elhassan, Yasir S., et al.
Publicado: (2019)

Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD(+) without impacting respiratory capacity or insulin sensitivity
por: Damgaard, Mads V., et al.
Publicado: (2022)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD(+) precursor nicotinamide riboside
por: Anugula, Sharath, et al.
Publicado: (2023)

Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies
por: Zarei, Amin, et al.
Publicado: (2021)

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
por: Berven, Haakon, et al.
Publicado: (2023)

The Clinical Effects of Nicotinamide Riboside on Inflammatory Parameters
por: Kwon, Jun, et al.
Publicado: (2022)

Emerging Role of Nicotinamide Riboside in Health and Diseases
por: Sharma, Chiranjeev, et al.
Publicado: (2022)

Ocular injuries from exploding glass-bottled Coca-Cola(®) drinks in Port Harcourt, Nigeria
por: Pedro-Egbe, Chinyere Nnenne, et al.
Publicado: (2011)

Treatment of gastric phytobezoars with Coca-Cola(®) given via oral route: a case report
por: Ertuğrul, Gökhan, et al.
Publicado: (2012)

Acute Intestinal Obstruction Caused by a Persimmon Phytobezoar after Dissolution Therapy with Coca-Cola
por: Ha, Seung Soo, et al.
Publicado: (2007)

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
por: Vreones, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0gvpnq42dk3n17ea8139eh61n